drugset / Trial / NCT01491503

A Drug Interaction Study of Montelukast and Levocetirizine

NCT01491503

Phase 1 Completed 30 enrolled Hanmi Pharmaceutical Company Limited
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the drug-drug interaction between montelukast sodium and levocetirizine dihydrochloride in healthy male volunteers.

Timeline

Start
2011-11
Primary completion
2012-01
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levocetirizine Unknown 5 mg
Comparator Montelukast Other / unclassified 10 mg

Indications

No indication recorded.